Similarly, glioblastoma (WHO IV) revealed a higher expression of XPO1 compared to WHO II gliomas, with no differences compared to WHO III gliomas in the TCGA cohort (Figure 2B). The gene discussed is XPO1; the disease is glioblastoma.